Explore how thoughtful, well-supported transportation strategies can reduce barriers, enhance participant retention, and strengthen the overall success of clinical trials.
INSIGHTS ON CLINICAL TRIAL DESIGN
-
![How AI Can Accelerate Clinical Trial and Registry Builds Carley Nolan]( "How AI Can Accelerate Clinical Trial And Registry Builds")
How AI Can Accelerate Clinical Trial And Registry BuildsAI tools speed study design — from protocol creation to validation and analysis — by automating complex tasks and generating intelligent data while preserving control, accuracy, and flexibility.
-
![GettyImages-1000908432 car keys]( "Providing Clinical Trial Patients With Transportation")
-
![GettyImages-1477214805-cancer-cell-targeted]( "Challenges That Derail Bladder Cancer Trials And How To Anticipate Them Earlier")
Challenges That Derail Bladder Cancer Trials And How To Anticipate Them EarlierFrom the rapid evolution of standard-of-care benchmarks to the logistical strain of procedure-heavy urology workflows, the path to a successful endpoint is filled with operational friction.
-
![thermo PPD webinar]( "How To Improve Patient ID And Retention In Chronic Disease Trials")
How To Improve Patient ID And Retention In Chronic Disease TrialsLeveraging primary care for chronic disease studies can accelerate patient identification, access to underrepresented populations, and improve retention rates.
-
How To Reduce Eligibility Risk And Prevent Protocol Deviations3/18/2026
Eliminate enrollment-based protocol deviations and align with the latest FDA guidance by implementing a centralized, technology-enabled eligibility review to safeguard trial integrity.
-
How Mobile Clinics Advance Diversity In Clinical Research12/4/2025
Mobile clinics reduce participation barriers, enable more inclusive trials, deliver representative data, speed timelines, and advance equity in research.
-
Accelerating IND-Enabling Studies With Automated Bioanalysis Workflows9/2/2025
Reimagined as automation-first, bioanalysis shifts from being an Investigational New Drug (IND) bottleneck to a catalyst for innovation—helping companies move therapies forward with greater confidence.
-
Expectations For Plain Language Summaries Continue To Evolve11/7/2025
Plain language summaries (PLS) are growing in importance as a requirement in global transparency. Focusing on protocol and results summaries, we cover expectations and best practices for global PLS implementation.
-
How Smarter Financial Strategies Improve Trial Performance3/10/2025
CROs play a critical role in ensuring the financial and operational success of clinical trials, yet outdated budgets and inefficient payment processes continue to create challenges for sites.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-1181024482 payment]( "Site And Patient Payments")
With integrations at the heart of our efficiency model, Block Clinical automates payments in three areas: Site Payments, Patient Payments, and Supplier Payments.
-
![GettyImages-1414481878 clinical trial, patient, diversity]( "How Trial Compass Is Solving Psychiatric Trial Enrollment")
Psychiatric trials have long been among the most difficult to enroll. From treatment-resistant depression (TRD) and PTSD to cognitive and neuro disorders, sponsors are facing the same challenges over and over again:
- Narrow I/E criteria that don’t translate into real-world patients
- Sites with limited behavioral health infrastructure
- Lack of patient trust and trial awareness in psychiatric populations
- Professional patients
- Rating scales aren’t used in clinical practices
But what if recruitment didn’t have to start with a gamble?
-
When considering clinical trial disclosure solutions, it is important to understand the potential partner’s practical experience and how their solution fits your compliance needs today and in the future.
-
![Clinicians doctors meeting iStock-1264556832]( "Think Bold. Think Scientific. Think Veristat.")
Veristat harnesses knowledge, expertise, and scale to provide superior solutions and progressive approaches to mitigate risks and achieve meaningful outcomes for biopharmaceutical and medical technology companies, and their patients.
-
![GettyImages-904483784 doctor patient]( "Clinical Trial Site Selection And Management")
Our network of 150+ active clinical trial sites allows us to identify potential partners that align with your therapeutic area, geographic preference, and specialty population requirements.
